Huons Co., Ltd. (243070) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Huons Co., Ltd. (243070:KRX), powered by AI.

Current Price
₩28,800
P/E Ratio
8.3
Market Cap
352.8B
Sector
Healthcare
What is the Huons Co., Ltd. stock price forecast?

Huons Co., Ltd. is currently trading at ₩28,800. View real-time AI analysis on Alpha Lenz.

What is Huons Co., Ltd. insider trading activity?

View the latest insider trading data for Huons Co., Ltd. on Alpha Lenz.

What is Huons Co., Ltd.'s P/E ratio?

Huons Co., Ltd.'s P/E ratio is 8.3.

Huons Co., Ltd.

KRX · 243070
₩28,800-650(-2.21%)Market closedKRX regular session 09:00–15:30 KST
Ask about Huons Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Huons Co., Ltd. trades at a P/E of 8.3 (undervalued) with solid ROE of 11.9%.

Ask for details

Company Overview

Huons Co., Ltd. is a distinguished biotechnology and pharmaceutical company headquartered in South Korea, primarily focused on the development, manufacture, and distribution of medical products and healthcare solutions. With a robust portfolio, Huons specializes in producing a diverse range of pharmaceuticals, including prescription drugs, over-the-counter products, and specialty remedies. The company plays a significant role in the healthcare sector by providing state-of-the-art medical equipment and cosmeceuticals, catering to both domestic and international markets. Huons is renowned for its commitment to innovation and quality, employing advanced research and development to enhance its product efficacy and safety. The company's impact spans across various sectors, including hospitals, clinics, and consumer health markets, aligning itself with the broader goals of improving health outcomes and access to reliable medical treatments. As a key player in the global pharmaceutical industry, Huons contributes significantly to medical advancements and healthcare delivery, reflecting its corporate mission of enhancing life quality through better healthcare solutions. Its strategic expansion and partnerships in multiple regions underline its market significance and commitment to growth and excellence in the biotech field.

CEOSong Soo-young
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees912

Company Statistics

FY 2025

Profile

₩352,801,134,250Market Cap
₩620,768,254,710Revenue
11.98MShares Out
912Employees

Margins

45.46%Gross
12.79%EBITDA
7.35%Operating
7.85%Pre-Tax
6.81%Net

Valuation

8.27P/E
0.94P/B
0.57EV/Sales
6.50EV/EBITDA
17.05P/FCF

Growth (CAGR)

8.03%Rev 3Yr
8.83%Rev 5Yr
3.72%Op Inc 3Yr
-3.37%Op Inc 5Yr
23.17%Net Inc 3Yr
-5.68%Net Inc 5Yr

Returns

6.57%ROA
11.85%ROE
8.55%ROIC

Financial Health

₩56,073,346,990Cash & Cash Equivalents
₩209,347,107,720Net Debt
63.98%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Huons Co., Ltd. (ticker: 243070) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 912 employees. Market cap is $352.8B.

The current price is ₩28,800 with a P/E ratio of 8.27x and P/B of 0.94x.

ROE is 11.85% and operating margin is 7.35%. Annual revenue is $620.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Huons Co., Ltd. (243070) Stock Forecast 2026 ₩28,800 — Price, Financials & Analyst Targets | Alpha Lenz